On-line Publication of Biomarker Panel that Forms Basis for NuroPro®PD Diagnostic Test OMAHA, Neb. and HOUSTON, Tex., September 2, 2009 — Transgenomic, Inc. (OTC BB: TBIO.OB) and Power3 Medical Products, Inc., (OTC BB:PWRM) today announced the advance on-line publication of a clinical research paper entitled “Abnormal Serum Concentrations of Proteins in Parkinson’s Disease” in the […]
Thermo Fisher Scientific Signs Agreement to Acquire Leading Provider of Specialty In-Vitro Diagnostic Tests – B.R.A.H.M.S. AG WALTHAM, Mass.–Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, has signed a definitive agreement to acquire B.R.A.H.M.S. AG for €330 million (approximately $470 million USD). B.R.A.H.M.S. is a leading provider of specialty in-vitro diagnostic […]
New Suite of Tests Identifies 2009 Influenza A H1N1 (“Swine Flu”), Additional Influenza Subtypes and Other Common Respiratory Viruses, Assisting Physicians in Improving Patient Care and Ensuring Appropriate Antiviral Use LEE’S SUMMIT, Mo. & LENEXA, Kan.–ViraCor-IBT Laboratories today launched a new, comprehensive influenza and respiratory virus testing service that will assist physicians in detecting a […]
PerkinElmer Launches First-in-Class Test Kit to Measure Multiple Steroids Simultaneously for Diagnosis of Hormone and Endocrine Disorders BREMEN, Germany, CHS(TM) Steroid Profiling Kit and Data Suite Software Delivers Faster and More Accurate Results for Endocrine Testing in Children and Adults At the 18th Annual International Mass Spectrometry Consortium meeting held in Bremen, Germany (https://www.imsc-bremen-2009.de/), PerkinElmer, […]
Seegene’s New Seeplex® FluA ACE Subtyping Test Accurately Differentiates Pandemic Novel Influenza A H1N1 and Seasonal Influenza A (H1, H3) Detecting Influenza A Virus Sub-Types Is Key to Treating Patients With Appropriate Antiviral Drugs ROCKVILLE, MD–(August 31, 2009) – Seegene today released a new influenza A sub-type screening test, Seeplex® FluA ACE Subtyping, that enables […]
Airborne and Food Allergens Identified Using Arrayit Instruments SUNNYVALE, CA–(August 27, 2009) – Arrayit Corporation (OTCBB: ARYC), a proprietary life sciences technology leader, announces the sale of instruments used to identify allergens in affected individuals. For allergy testing, allergens are printed onto proprietary glass substrates to form microarrays. Serum samples from individuals with allergies are […]
Haber Inc. Targeting Low Cost Diagnostic Testing for MD’s Offices Using Proprietary Separation Technology – Company forms subsidiary “EMP Diagnostics Inc.” to commercialize its unique technology for rapid, low cost blood diagnostic use by MD’s at point of service ARLINGTON, Mass.–Haber, Inc. (“Haber”), (OTC: HABE), a Delaware corporation headquartered in Arlington, Mass., with proprietary technologies […]
Focus Will Be on Ground-Breaking Molecular Tests for the Early Detection and Diagnosis of Neurodegenerative Disease and Cancer SUNNYVALE, CA–(08/12/09) – Arrayit Corporation (OTC.BB:ARYC – News), a proprietary life science technology leader, announces the incorporation of Arrayit Diagnostics, Inc., a majority owned Nevada Corporation, to be headquartered in Houston, Texas. The company is currently developing […]
New Company Offers Comprehensive Genomic Services BEVERLY, Mass., Aug. 12 — Beckman Coulter, Inc. (NYSE: BEC – News) today announced the creation of Beckman Coulter Genomics. The new company, which combines Agencourt Bioscience and the newly acquired Cogenics, offers researchers a single genomic services resource with expanded global capabilities. “Through the creation of Beckman Coulter […]
New Roche Mycoplasma PCR Test Replaces Time-Consuming Culture Testing During Pharmaceutical Production PENZBERG, Germany–In July 2009 the new MycoTOOL PCR test from Roche Applied Science was approved by the European Medicines Agency (EMEA) for release testing of a Roche pharmaceutical product. It is the first commercially available Mycoplasma PCR test that can replace traditional Mycoplasma […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
